Key findings revealed that BC significantly reduced PD-L1 levels in CRC cells by inhibiting its palmitoylation via DHHC3, preventing PD-L1 recycling to the cell membrane and redirecting it to lysosomal degradation. This evidence concerns the gene CD274 and breast cancer.